Present-day clinical treatments for stroke encompass thrombolytic therapy employing tissue plasminogen activator (tPA) for ischemic strokes, endovascular thrombectomy for clot removal, and surgical interventions for hemorrhagic strokes (Putaala, 2020). This evidence concerns the gene PLAT and hemorrhagic stroke.